Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: W Shakespeare who wrote (340)	11/30/1999 2:39:00 PM
From: MGV	Read Replies (1) \| Respond to of 413

W - "I was also fascinated by the increasing pressure that LVCI seems to be putting on VISX to lower procedure fees. LVCI has only 10% of the market at present, so I think that they do not have enough leverage at this point." That struck me as a little odd as well. It will be interesting to see what VISX negotiates with BOL and Lasersight. "If they could pull off a large merger, perhaps the scales would tip more in their favor. However, I view such an event to be well down the road." Agreed, but LVCI probably provides more business than Lasersight so the Lasersight license will be relevant. "Finally, I look for the results of the next quarter to be excellent. The company will well exceed the dampened expectations and will see another rise in its stock price. I applaud those who had the sense to buy on this senseless price drop. Fundamentals always win in the end." Pretty good statement of my sentiments as well.